Kinea Bio, Inc

Curi Bio, based in Seattle, is a team of experts dedicated to providing answers to any questions you may have. Their knowledgeable team members are ready to assist with any inquiries you might have. With a focus on customer service and expertise, Curi Bio aims to offer support and guidance to individuals seeking information. Trust in Curi Bio to address your queries and provide the assistance you need. Generated from their website's infomation

Established in 1991, Cell Therapeutics is a publicly owned biopharmaceutical company. The company develops a variety of oncology therapy products. It offers a range of cancer therapies and treatment programs. Cell Therapeutics also conducts clinical trials for ovarian and lung cancer. It handles the storage and distribution of clinical and commercial drug supplies. The company uses the Genetic Polymer technology. Its subsidiaries include Systems Medicine and Aequus BioPharma. Systems Medicine guides the development of several oncology products. Cell Therapeutics outsource drug substance and drug product production, release testing and distribution activities to contract manufacturing organizations and service providers in the United States and Europe.

TwinStrand Biosciences Inc, based in Seattle, WA, is a leading biotechnology company specializing in high-resolution DNA sequencing technology. Their flagship product, TwinStrand Duplex Sequencing, offers a revolutionary approach to next-generation sequencing, reducing error rates and revealing hidden data by independently tracking both strands of individual DNA molecules. With applications in measurable residual disease detection, mutation signatures, and variant identification, TwinStrand Duplex Sequencing provides researchers with unparalleled accuracy and resolution beyond standard NGS methods. Through a combination of proprietary biochemistry and cloud-based informatics, TwinStrand Biosciences is at the forefront of advancing mutagenesis testing and genomic research. Their technology has been validated in collaboration with renowned institutions such as Health Canada, demonstrating its potential to overcome limitations in current mutagenicity assays and provide novel insights into the mutagenic mode of action. With a commitment to scientific collaboration and innovation, TwinStrand Biosciences is revolutionizing the field of DNA sequencing and empowering researchers to unlock the full potential of genetic analysis.Generated from the website